#fda

Collection of fda news, found 198 news.

New Data Shows Lantus(R) Activation of Insulin Receptor Comparable to Human Insulin

New Data Shows Lantus(R) Activation of Insulin Receptor Comparable to Human Insulin

  • 27th June 2011

-        - Human and in vivo Studies Indicate Lantus(R) Metabolites do not ...

Lantus(R)/Apidra(R) SoloSTAR(R) Help to Improve Patient Satisfaction

Lantus(R)/Apidra(R) SoloSTAR(R) Help to Improve Patient Satisfaction

  • 27th June 2011

-        Sanofi (EURONEXT: SAN and NYSE: SNY) announced today, at the 71st Scientific ...

Phadia First Company to Receive FDA Clearance of Recombinant Allergen Component Tests

Phadia First Company to Receive FDA Clearance of Recombinant Allergen Component Tests

  • 21st June 2011

-510(K) Clearance Covers 13 Molecular Allergen Components     Newly-available tests provide deepest ...

Synthes and Lilly Sign Development and Collaboration Agreement

Synthes and Lilly Sign Development and Collaboration Agreement

  • 10th June 2011

-        Synthes, Inc. (SIX: SYST.VX) and Eli Lilly and Company (NYSE: LLY) today ...

Edison Pharmaceuticals to Provide Expanded Access to EPI-743 for Mitochondrial Disease

Edison Pharmaceuticals to Provide Expanded Access to EPI-743 for Mitochondrial Disease

  • 8th June 2011

-FDA allows use of investigational new drug for life-threatening indications     Edison ...

Edison Pharmaceuticals Announces FDA Grants EPI-743 Orphan Drug Designation

Edison Pharmaceuticals Announces FDA Grants EPI-743 Orphan Drug Designation

  • 8th June 2011

-Designation covers inherited respiratory chain diseases of the mitochondria    Edison Pharmaceuticals, ...

Four Phase 3 Efficacy and Safety Studies of Ingenol Mebutate

Four Phase 3 Efficacy and Safety Studies of Ingenol Mebutate

  • 7th June 2011

-        - NOT INTENDED FOR US MEDIA    - Ingenol Mebutate is an ...

Sanofi's Investigational Semuloparin in Cancer Patients Initiating Chemotherapy Shows a 64 % Risk Re

Sanofi's Investigational Semuloparin in Cancer Patients Initiating Chemotherapy Shows a 64 % Risk Re

  • 6th June 2011

-        - Results of Phase III SAVE-ONCO Study Selected for "Best of ASCO 2011" ...

Thailand detects low-level radiation in vegetables from Japan

Thailand detects low-level radiation in vegetables from Japan

  • 2nd April 2011

Thailand`s Food and Drug Administration (FDA) on Thursday said a low-level of radiation was found in one kilogramme of ...

2011 ACCF/AHA Guidelines Incorporate New Recommendation for Platelet Reactivity Testing

2011 ACCF/AHA Guidelines Incorporate New Recommendation for Platelet Reactivity Testing

  • 31st March 2011

-    Platelet Function Testing May Be Used to Aid Patient Management    Accumetrics, ...

Thailand Lakukan Pemeriksaan Makanan Impor dari Jepang

Thailand Lakukan Pemeriksaan Makanan Impor dari Jepang

  • 25th March 2011

Badan Obat dan Makanan Thailand (FDA) telah memerintahkan pemeriksaan acak bagi segala makanan dan meminta importir ...

MASEP Infini Announces U.S. FDA 510(k) Clearance of State-of-the-art, Non-invasive Stereotactic Neur

MASEP Infini Announces U.S. FDA 510(k) Clearance of State-of-the-art, Non-invasive Stereotactic Neur

  • 24th March 2011

-     The New Infini(TM) System Provides Healthcare Systems with an Alternative System for ...

US blocks milk, produce from Japan near nuclear plant

US blocks milk, produce from Japan near nuclear plant

  • 23rd March 2011

The United States will block imports of milk and fresh produce from areas of Japan near a crippled nuclear power ...

Phase III Results Show Mirabegron Improves Key OAB Symptoms

Phase III Results Show Mirabegron Improves Key OAB Symptoms

  • 21st March 2011

-        - First Presentations of European-Australian and North American Phase III Trials ...

Accumetrics Announces Publication of GRAVITAS Primary Results in JAMA

Accumetrics Announces Publication of GRAVITAS Primary Results in JAMA

  • 16th March 2011

-Evaluation of Alternative Treatment Strategies Incorporating Platelet Function Testing Recommended    ...